Qiagen stock pre-market at EUR 40.45: minus 0.32 percent
Published on 10/07/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Qiagen stock was at EUR 40.45 pre-market at Lang & Schwarz at 8:14 a.m. CEST on October 7, 2026. The price was minus 0.32 percent versus the Lang & Schwarz prior close of EUR 40.58 on October 6, 2026.
Pre-market trading
The Lang & Schwarz bid was EUR 40.22 and the ask was EUR 40.68. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Qiagen stock.
QIAGEN expands AI capabilities
In a press release dated October 6, 2026, QIAGEN announced new artificial-intelligence capabilities for analyzing biological and genomic data. The offering includes IPA Investigator, which allows researchers to ask biological questions in natural language, and the QIAGEN Discovery Platform, which extends AI into drug-discovery workflows.
QIAGEN said the new offerings build on more than 25 years of biomedical knowledge from QIAGEN Digital Insights, whose bioinformatics solutions are used by around 150,000 users, according to the release.
